Found 410 ctsi-central-admin trials
A listing of ctsi-central-admin medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
The purposes of this study are to: (1) find the most effective dose of a new type of radiation therapy called total marrow irradiation (TMI) that will be given with the conditioning chemotherapy, fludarabine, to prepare patients for allogeneic hematopoietic stem cell transplantation (Allo-HSCT); and (2) see if utilization of …
This study aims to invent a test that can see tiny pieces from your cancer (specifically DNA from your cancer) in blood and urine better than tests that can currently be done. In the future, this test can possibly be used to find a small cancer before other tests can …
![The Hoosier Moms Cohort !@#$%^*()_+{}|:"?`-=[]/~abcdefghijklmnopqrstuvwxyzABCDEFGHIJKLMNOPQRSTUVWXYZ1234567890 end](/media/img/trial_thumbnails/_0017_Pregnancy_1.png)
The purpose of this study is to better understand how Gestational Diabetes Mellitus (GDM, high blood sugar in pregnancy) develops. We hope to understand the differences between women who are diagnosed with GDM and those who are not. Another purpose is to understand how GDM can progress to Type 2 …
The purpose of this study is to investigate the effects of beetroot juice consumption on the ability to exercise. We are also interested in understanding how beetroot juice may improve blood vessel function in postmenopausal women.
The purpose of this study is to better understand what factors, demographic characteristics, and interventions predict better recovery-related outcomes.
This phase II trial studies how well giving radiation therapy together with gemcitabine hydrochloride and cisplatin work in treating patients with locally advanced squamous cell carcinoma of the vulva.
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy.
This phase II trial studies how well radiation therapy with or without olaparib works in treating patients with inflammatory breast cancer.
The purpose of this study is to estimate the pathological complete response rate at the time of surgery in patients with stage IIIA (N2) NSCLC treated with concurrent Carboplatin/Paclitaxel/Durvalumab plus radiation therapy followed by surgical resection followed by adjuvant Durvalumab.
The purpose of this study is to compare any good and bad effects of usual radiation plus the study treatment, MEDI4736 (durvalumab), to the usual therapy of radiation plus cetuximab in patients with head and neck cancer who cannot take the drug cisplatin.
